State Street Corp Cure Vac N.V. Transaction History

State Street Corp

$2.8 Trillion
Q3 2025

A detailed history of State Street Corp transactions in Cure Vac N.V. stock. As of the latest transaction made, State Street Corp holds 124,833 shares of CVAC stock, worth $659,118. This represents 0.0% of its overall portfolio holdings.

Number of Shares

124,833

Previous 56,252 121.92%

Holding current value

$659,118

Previous $305,000 120.33%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$5.34 - $5.51 $366,222 - $377,881	68,581 Added 121.92%	124,833 $672,000
Q2 2025 Aug 14, 2025	BUY	$2.59 - $5.6 $3,227 - $6,977	1,246 Added 2.27%	56,252 $305,000
Q1 2025 May 15, 2025	BUY	$2.77 - $4.68 $11,575 - $19,557	4,179 Added 8.22%	55,006 $152,000
Q4 2024 Feb 14, 2025	BUY	$2.49 - $3.41 $1,934 - $2,649	777 Added 1.55%	50,827 $173,000
Q3 2024 Nov 14, 2024	BUY	$2.74 - $3.79 $1,304 - $1,804	476 Added 0.96%	50,050 $147,000

Q2 2024 Aug 14, 2024	BUY	$2.31 - $4.99 $2,279 - $4,925	987 Added 2.03%	49,574 $168,000
Q1 2024 May 15, 2024	BUY	$2.94 - $4.34 $4,939 - $7,291	1,680 Added 3.58%	48,587 $147,000
Q4 2023 Feb 14, 2024	SELL	$3.96 - $6.41 $324,882 - $525,882	-82,041 Reduced 63.62%	46,907 $197,000
Q3 2023 Nov 14, 2023	BUY	$6.5 - $10.77 $15,229 - $25,234	2,343 Added 1.85%	128,948 $880,000
Q2 2023 Aug 14, 2023	SELL	$6.69 - $12.25 $934,037 - $1.71 Million	-139,617 Reduced 52.44%	126,605 $1.32 Million
Q1 2023 May 15, 2023	BUY	$6.38 - $12.5 $56,277 - $110,262	8,821 Added 3.43%	266,222 $1.86 Million
Q4 2022 Feb 14, 2023	BUY	$5.75 - $8.5 $1.04 Million - $1.54 Million	181,348 Added 238.45%	257,401 $1.55 Million
Q3 2022 Nov 15, 2022	SELL	$7.48 - $15.24 $263,348 - $536,554	-35,207 Reduced 31.64%	76,053 $599,000
Q2 2022 Aug 15, 2022	SELL	$13.18 - $19.41 $6.99 Million - $10.3 Million	-530,059 Reduced 82.65%	111,260 $1.51 Million
Q1 2022 May 16, 2022	BUY	$14.73 - $35.25 $562,273 - $1.35 Million	38,172 Added 6.33%	641,319 $12.6 Million
Q4 2021 Feb 14, 2022	BUY	$33.72 - $48.22 $2.44 Million - $3.49 Million	72,363 Added 13.63%	603,147 $20.7 Million
Q3 2021 Nov 15, 2021	BUY	$49.26 - $74.5 $2.66 Million - $4.03 Million	54,057 Added 11.34%	530,784 $29 Million
Q2 2021 Aug 16, 2021	BUY	$56.91 - $127.53 $26.6 Million - $59.7 Million	468,027 Added 5379.62%	476,727 $35 Million
Q1 2021 May 17, 2021	BUY	$79.79 - $126.29 $694,173 - $1.1 Million	8,700 New	8,700 $796,000

Others Institutions Holding CVAC

# of Institutions

108

Shares Held

22.5M

Call Options Held

124K

Put Options Held

77.1K

View Full List

About CureVac N.V.

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $990M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

More about CVAC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Cure Vac N.V. Transaction History